411 related articles for article (PubMed ID: 26053285)
21. Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years.
Aguiar R; Araújo C; Martins-Coelho G; Isenberg D
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):257-262. PubMed ID: 27110698
[TBL] [Abstract][Full Text] [Related]
22. Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide.
Lehman TJ; Singh C; Ramanathan A; Alperin R; Adams A; Barinstein L; Moorthy N
Pediatr Rheumatol Online J; 2014 Jan; 12():3. PubMed ID: 24423147
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
Jiang B; Li T; Guo L; Shen H; Ye S; Chen S
J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
[TBL] [Abstract][Full Text] [Related]
24. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
25. Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.
Ramos-Casals M; Soto MJ; Cuadrado MJ; Khamashta MA
Lupus; 2009 Aug; 18(9):767-76. PubMed ID: 19578100
[TBL] [Abstract][Full Text] [Related]
26. Rituximab therapy in refractory neuropsychiatric lupus: current clinical evidence.
Narváez J; Ríos-Rodriguez V; de la Fuente D; Estrada P; López-Vives L; Gómez-Vaquero C; Nolla JM
Semin Arthritis Rheum; 2011 Dec; 41(3):364-72. PubMed ID: 21875742
[TBL] [Abstract][Full Text] [Related]
27. Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.
Garcia-Carrasco M; Mendoza-Pinto C; Sandoval-Cruz M; Soto-Vega E; Beltran-Castillo A; Jimenez-Hernandez M; Graillet D; Gonzalez L; Rojas-Rodriguez J; Pineda-Almazana A; Zamudio-Huerta L; Lopez-Colombo A
Lupus; 2010 Feb; 19(2):213-9. PubMed ID: 19965944
[TBL] [Abstract][Full Text] [Related]
28. Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.
Braun-Moscovici Y; Butbul-Aviel Y; Guralnik L; Toledano K; Markovits D; Rozin A; Nahir MA; Balbir-Gurman A
Rheumatol Int; 2013 Jun; 33(6):1495-504. PubMed ID: 23239037
[TBL] [Abstract][Full Text] [Related]
29. Long-term real-life experience with rituximab in adult Finnish patients with rheumatoid arthritis refractory or with contraindication to anti-tumor necrosis factor drugs.
Valleala H; Korpela M; Hienonen-Kempas T; Immonen K; Lähteenmäki J; Uusitalo T; Komulainen R; Möttönen T; Hannonen P
J Clin Rheumatol; 2015 Jan; 21(1):24-30. PubMed ID: 25539430
[TBL] [Abstract][Full Text] [Related]
30. Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
McCarthy EM; Sutton E; Nesbit S; White J; Parker B; Jayne D; Griffiths B; Isenberg DA; Rahman A; Gordon C; D'Cruz DP; Rhodes B; Lanyon P; Vital EM; Yee CS; Edwards CJ; Teh LS; Akil M; McHugh NJ; Zoma A; Bruce IN;
Rheumatology (Oxford); 2018 Mar; 57(3):470-479. PubMed ID: 29216396
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of rituximab in a chart review study of 15 patients with systemic lupus erythematosus.
Hickman RA; Hira-Kazal R; Yee CS; Toescu V; Gordon C
Clin Rheumatol; 2015 Feb; 34(2):263-71. PubMed ID: 25564308
[TBL] [Abstract][Full Text] [Related]
32. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
34. Rituximab treatment in lupus nephritis--where do we stand?
Gunnarsson I; Jonsdottir T
Lupus; 2013 Apr; 22(4):381-9. PubMed ID: 23553781
[TBL] [Abstract][Full Text] [Related]
35. Lower doses of rituximab in remission induction for refractory granulomatosis with polyangiitis.
Wawrzycka-Adamczyk K; Zugaj A; Włudarczyk A; Kosałka J; Sznajd J; Bazan-Socha S; Musiał J
Przegl Lek; 2014; 71(12):663-5. PubMed ID: 25951692
[TBL] [Abstract][Full Text] [Related]
36. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
Pusongchai T; Jungthirapanich J; Khositseth S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy.
Tanaka Y; Takeuchi T; Miyasaka N; Sumida T; Mimori T; Koike T; Endo K; Mashino N; Yamamoto K
Mod Rheumatol; 2016; 26(1):80-6. PubMed ID: 26054418
[TBL] [Abstract][Full Text] [Related]
38. Rituximab therapy for childhood-onset systemic lupus erythematosus.
Willems M; Haddad E; Niaudet P; Koné-Paut I; Bensman A; Cochat P; Deschênes G; Fakhouri F; Leblanc T; Llanas B; Loirat C; Pillet P; Ranchin B; Salomon R; Ulinski T; Bader-Meunier B;
J Pediatr; 2006 May; 148(5):623-627. PubMed ID: 16737873
[TBL] [Abstract][Full Text] [Related]
39. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.
Lu TY; Ng KP; Cambridge G; Leandro MJ; Edwards JC; Ehrenstein M; Isenberg DA
Arthritis Rheum; 2009 Apr; 61(4):482-7. PubMed ID: 19333973
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.
Ale'ed A; Alsonbul A; Al-Mayouf SM
Rheumatol Int; 2014 Apr; 34(4):529-33. PubMed ID: 24218286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
